STUDY SEARCH RESULTS

1 study found for your search request:  8591-013

Dose Ranging, Switch Study of Islatravir (MK-8591) and Ulonivirine (MK-8507) Once-Weekly in Virologi...
Condition: HIV-1 infection
Minimum Age: 18 years, Maximum Age: N/A
Gender: All
Study ID: NCT04564547
Status: Completed
Has Results




Copyright © 2026 · Merck & Co., Inc., Rahway, NJ, USA, and its affiliates. All rights reserved. · This site is intended only for residents of the United States.
Cookie Preferences  Privacy  Terms of Use  Consumer Health Data Privacy Policy  Your Privacy Choices   Accessibility  U.S. Corporate Site